AmplifiDx
PrivateLast Round
Grant
Apr 15, 2026
Total Funding Raised
$2.43M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
AmplifiDx operates in Healthcare & Life Sciences and is based in Newark, California. Its latest recorded funding round was a Grant round in April 2026.
AmplifiDx is a life sciences company that develops molecular point-of-care diagnostic platforms for the rapid detection of infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AmplifiDx Comparables
Compare AmplifiDx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Anavasi Diagnostics | 90% | |
| Alveo Technologies | 83% | |
| QuidelOrtho | 82% |
For institutional investors. Book with your work email.
AmplifiDx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 15, 2026 | ||||
| Grant | Dec 3, 2024 | ||||
| Grant | May 15, 2023 | ||||
| Seed | Jul 23, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AmplifiDx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Biomedical Imaging and Bioengineering | Grant |
| Shepherd Ventures III | Seed |
| National Institute of Allergy and Infectious Diseases | Grant |
| Beacon Angels | Seed |
| Avestria Ventures | Seed |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 31% MoM.
- Aug 20, 2026
Monthly visitors grew 2360% MoM, from 42 to 1K.
For institutional investors. Book with your work email.
AmplifiDx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AmplifiDx's valuation, stock price, and market status.
Is AmplifiDx a public or private company?
AmplifiDx is a private company.
What is the current stock price of AmplifiDx?
AmplifiDx is a private company, so its shares have no public market price. Caplight tracks AmplifiDx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AmplifiDx worth (valuation)?
Valuation information for AmplifiDx is not publicly available.
Can I buy AmplifiDx stock?
AmplifiDx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AmplifiDx's last funding round?
AmplifiDx's most recent funding round was Grant on April 15, 2026.
Who are the main investors in AmplifiDx?
Key investors in AmplifiDx include National Institute of Biomedical Imaging and Bioengineering, Shepherd Ventures III, National Institute of Allergy and Infectious Diseases, Beacon Angels, Avestria Ventures.
Will AmplifiDx IPO soon?
No public IPO plans have been announced for AmplifiDx.
How can I track AmplifiDx secondary market activity?
Caplight tracks bids, offers, and trades in AmplifiDx's shares on secondary markets.